• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

SMG 1410.501

FDA STAFF MANUAL GUIDES, VOLUME II - DELEGATIONS OF AUTHORITY

REGULATORY - ANIMAL DRUGS

ISSUANCE OF FEDERAL REGISTER DOCUMENTS PERTAINING TO THE DETERMINATION OF SAFE LEVELS, NOTICE OF NEED FOR DEVELOPMENT OF AN ANALYTICAL METHOD, NOTICE OF AVAILABILITY OF A DEVELOPED ANALYTICAL METHOD, AND PROHIBITION OF CERTAIN EXTRALABEL DRUG USE

Effective Date: 02/24/2011

[PDF Version]

1. AUTHORITY DELEGATED AND TO WHOM DELEGATED.

The Director, the Deputy Director, and the Senior Advisor for Science Policy, Center for Veterinary Medicine (CVM), are authorized to issue Federal Register documents pertaining to the determination of safe levels, notice of need for development of an analytical method, notice of availability of a developed analytical method, and prohibition of certain extra label drug use related to implementation of Section 512(a)(4) and (5) of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 360b(a)(4) and (5)).

2. REDELEGATION.

These officials may further redelegate this authority.

3. EFFECTIVE DATE.

The Commissioner of Food and Drugs approved this delegation on February 24, 2011.

STATUS (I, R, C)DATE APPROVEDLOCATION OF CHANGE HISTORYCONTACTAPPROVING OFFICIAL
Initial02/24/2011N/aCVM/OMCommissioner of Food and Drugs